Study Summary
This trial will test whether semaglutide, an FDA-approved diabetes and obesity drug, can improve asthma control in adults who are overweight and not well-controlled with inhaled steroids.
- Asthma
Treatment Effectiveness
Effectiveness Progress
Study Objectives
2 Primary · 6 Secondary · Reporting Duration: Baseline to week 4 and week 12
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Study Drug (Semaglutide)
1 of 2
Placebo
1 of 2
Experimental Treatment
Non-Treatment Group
100 Total Participants · 2 Treatment Groups
Primary Treatment: Semaglutide Pen Injector 2.4mg weekly · Has Placebo Group · Phase 2
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Does this trial still accept participants?
"Affirmative. According to clinicaltrials.gov, this medical experiment is actively recruiting participants; the study was first posted on September 7th 2022 and recently updated on the 9th of that same month. The research seeks approximately 100 subjects from a single site." - Anonymous Online Contributor
Is the 2.4mg weekly dosage of Semaglutide Pen Injector officially sanctioned by the FDA?
"Although the efficacy of Semaglutide Pen Injector 2.4mg weekly is yet to be verified, there has been enough evidence gathered on its safety for it to receive a score of 2 out of 3." - Anonymous Online Contributor
What is the key aim of this trial?
"This clinical trial will examine the impacts of semaglutide administered weekly over a Baseline to week 12 time frame on serum periostin in subjects with symptomatic, persistent asthma and obesity. Secondary objectives include evaluating weight loss from baseline at week 24, establishing changes in exhaled nitric oxide levels between weeks 4 and 12, and measuring efficacy as indicated by ACQ-6 scores (0-6; lower is better) after twelve weeks." - Anonymous Online Contributor
How many participants are being tracked in this research study?
"Affirmative. Records on clinicaltrials.gov demonstrate that, as of 9/9/2022, this clinical research is actively seeking participants to participate at one site with a goal of 100 enrollees. The trial was initially posted the 7th September 2022." - Anonymous Online Contributor